Two months ago, Maryland became the first state in the country to pass legislation banning price gouging by manufacturers of generic and off-patent drugs. This is landmark legislation. However, much more needs to be done.
On Wednesday, I endorsed the Prescription Drug Affordability Initiative at a press conference organized by Maryland Health Care for All. Drug makers talk about the importance of innovation, and while we encourage research and development, physicians, patients, and family members have a right to know why medications are priced as they are. We have a right to know why medications that used to be affordable are no longer. We have a right to know about alternatives that may cost a lot less, but are just as effective. We have a right to transparent and accurate information, and a right to affordable healthcare.
Subscribe to the Bmore Healthy newsletter.